首页> 美国卫生研究院文献>BMJ Open Access >Original research article: Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction

【2h】

Original research article: Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction

机译：原始研究文章：沙比特比/缬沙坦治疗射血分数降低的心力衰竭的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveChronic heart failure with reduced ejection fraction (HF-REF) represents a major public health issue and is associated with considerable morbidity and mortality. We evaluated the cost-effectiveness of sacubitril/valsartan (formerly LCZ696) compared with an ACE inhibitor (ACEI) (enalapril) in the treatment of HF-REF from the perspective of healthcare providers in the UK, Denmark and Colombia.

机译：客观的射血分数降低的慢性心力衰竭（HF-REF）代表了主要的公共卫生问题，并与相当的发病率和死亡率相关。从英国，丹麦和哥伦比亚的医疗保健提供者的角度，我们评估了沙比特比尔/缬沙坦（以前为LCZ696）与ACE抑制剂（ACEI）（依那普利）相比在HF-REF治疗中的成本效益。

著录项

期刊名称 BMJ Open Access
作者
John J V McMurray; David Trueman; Elizabeth Hancock; Martin R Cowie; Andrew Briggs; Matthew Taylor; Juliet Mumby-Croft; Fionn Woodcock; Michael Lacey; Rola Haroun; Celine Deschaseaux;
展开▼
作者单位

展开▼
年(卷),期 -1(104),12
年度 -1
页码 1006–1013
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
heart failure with reduced ejection fraction health care economics quality and outcomes of care;

机译：射血分数降低的心力衰竭;医疗保健经济学;护理质量和结果;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal [J] . Nature reviews Cancer . 2020,第2期

机译：Sacubitril / Valsartan的成本效果用于治疗心力衰竭患者在葡萄牙中的射血分数降低
2. THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: THE USE OF MODEL CALIBRATION TO IMPROVE GENERALISABILITY TO A UK CHF POPULATION [J] . Hancock E., Trueman D., Jhund P., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：尿嘧啶/缬沙坦治疗降低射血分数的慢性心力衰竭的成本效益：使用模型校正可提高英国CHF人群的一般易感性
3. THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ENGLAND AND SCOTLAND: APPLYING REAL-WORLD EVIDENCE TO ENHANCE GENERALISABILITY TO A UK POPULATION [J] . Trueman D., Hancock E., Jhund P., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：尿嘧啶/缬沙坦治疗英格兰和苏格兰减少的射血分数减少的慢性心力衰竭的成本效益：应用真实证据来增强英国人口的通用性
4. Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction [C] . C Schoebel, I Fietze, T Penzel Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：优化的心力衰竭药物对慢性心力衰竭左心室射血分数降低的Cheyne-Stokes呼吸模式对中枢性睡眠呼吸暂停的影响
5. Efficacy of Sacubitril/Valsartan in the Treatment of Women with Heart Failure with Preserved Ejection Fraction [D] . Lee, Rita Joyce. 2020

机译：Sacubitril / Valsartan在患有射血分数的心力衰竭治疗妇女的疗效
6. Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study [O] . Sashiananthan Ganesananthan, Nisar Shah, Parin Shah, 2020

机译：射入射入分数减少的心力衰竭患者的真实世界治疗切换到Sacubitril / Valsartan：队列研究
7. Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal [O] . Margarida Borges, Marta Afonso-Silva, Pedro A. Laires, 2019

机译：Sacubitril / Valsartan的成本效果用于治疗心力衰竭患者在葡萄牙中的射血分数降低

Original research article: Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction

摘要

著录项

相似文献

相关主题

期刊订阅